Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Medical condition to be studied

Chronic obstructive pulmonary disease
Population studied

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

40000
Study design details

Main study objective

To study the role of high blood eosinophil counts in the burden and costs of COPD in a broad real-life population of patients in the UK

Outcomes

COPD exacerbation rate for objective 1, COPD-related short-term rehospitalisation for objective 2, COPD-related HRU and costs for objectives 3&4,

Data analysis plan

Binomial regression will be performed to estimate the adjusted association between high BEC and COPD exacerbations for objective 1.Cox-regression will be performed to estimate the adjusted association between high BEC and rehospitalisation for objective 2.HRU and mean costs will be described for different subgroups of patients on triple therapy who are at risk of exacerbations for objective 3.A one- or two-step generalized linear model with gamma distribution and log link will be used to perform regression analysis with total costs as the outcome variable for objective 4.